|Title of Study||
XAMINA / Xarelto® on prevention of stroke and non-central nervous system systeMIc embolism in treatment Naïve Asian patients with non-valvular atrial fibrillation.
The primary objective is to assess the safety of rivaroxaban regarding the rate of major bleeding in treatment naïve NVAF patients under clinical practice conditions.
|Number of Sites||
|Period of Study||
From：September 2017 to：September 2019
|Number of Patients||
|IRB Approval Date||
|Publication Plan / Date||